These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31203535)

  • 1. Creating three dimensional models of the right ventricular outflow tract: influence of contrast, sequence, operator, and threshold.
    Burkhardt BEU; Brown NK; Carberry JE; Velasco Forte MN; Byrne N; Greil G; Hussain T; Tandon A
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):2067-2076. PubMed ID: 31203535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved high-resolution pediatric vascular cardiovascular magnetic resonance with gadofosveset-enhanced 3D respiratory navigated, inversion recovery prepared gradient echo readout imaging compared to 3D balanced steady-state free precession readout imaging.
    Tandon A; Hashemi S; Parks WJ; Kelleman MS; Sallee D; Slesnick TC
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):74. PubMed ID: 27802802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-assessment of RVOT dimensions prior percutaneous pulmonary valve implantation: comparison of contrast-enhanced magnetic resonance angiography versus 3D steady-state free precession sequence.
    Ebel S; Gottschling S; Buzan MTA; Grothoff M; Dähnert I; Wagner R; Gräfe D; Lurz P; Gutberlet M; Lücke C
    Int J Cardiovasc Imaging; 2019 Aug; 35(8):1453-1463. PubMed ID: 30937683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study.
    Tandon A; James L; Henningsson M; Botnar RM; Potersnak A; Greil GF; Hussain T
    J Cardiovasc Magn Reson; 2016 Oct; 18(1):66. PubMed ID: 27716273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
    Johnson JT; Robinson JD; Deng J; Rigsby CK
    Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Part 2 - Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging.
    Ahlman MA; Raman FS; Pang J; Zemrak F; Sandfort V; Penzak SR; Fan Z; Liu S; Li D; Bluemke DA
    BMC Cardiovasc Disord; 2016 Mar; 16():58. PubMed ID: 27004532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
    Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
    J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses.
    Veldhoen S; Oechsner M; Fischer A; Weng AM; Kunz AS; Bley TA; Köstler H; Ritter CO
    Invest Radiol; 2016 Mar; 51(3):186-93. PubMed ID: 26606550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
    Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
    J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
    J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.
    Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC
    Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia.
    Hennig A; Salel M; Sacher F; Camaioni C; Sridi S; Denis A; Montaudon M; Laurent F; Jais P; Cochet H
    Europace; 2018 Sep; 20(FI2):f179-f191. PubMed ID: 29069369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a semi-automated cardiac segmentation tool improves reproducibility and speed of segmentation of contaminated right heart magnetic resonance angiography.
    Tandon A; Byrne N; Nieves Velasco Forte Mde L; Zhang S; Dyer AK; Dillenbeck JM; Greil GF; Hussain T
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1273-9. PubMed ID: 27173489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
    Al-Wakeel-Marquard N; Rastin S; Muench F; O H-Ici D; Yilmaz S; Berger F; Kuehne T; Messroghli DR
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1961-1968. PubMed ID: 28620681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.